Radiation-induced brain tumours in nevoid basal cell carcinoma syndrome: Implications for treatment and surveillance

Child's Nervous System

Volumn 23, Issue 1, 2007, Pages 133-136

  Choudry, Q ^a   Patel, H C ^a   Gurusinghe, N T ^a   Evans, D G ^b  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

Medulloblastoma; NBCCS; Radiation induced secondary tumours

Indexed keywords

PROTEIN PATCHED;

ADOLESCENT; ADULT; ARTICLE; BASAL CELL NEVUS SYNDROME; BRAIN TUMOR; CANCER RADIOTHERAPY; CASE REPORT; CHILD; CHROMOSOME 9Q; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; CRANIECTOMY; EXON; FAILURE TO THRIVE; FAMILY HISTORY; FEMALE; FOLLOW UP; GLASGOW COMA SCALE; HISTOPATHOLOGY; HUMAN; HYDROCEPHALUS; INFANT; LANGUAGE DISABILITY; LEARNING DISORDER; MEDICAL DECISION MAKING; MEDULLOBLASTOMA; NEUROSURGERY; NONSENSE MUTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ASTROCYTOMA; BASAL CELL NEVUS SYNDROME; BRAIN NEOPLASMS; CEREBELLAR NEOPLASMS; FEMALE; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; NEOPLASMS, RADIATION-INDUCED; RADIOTHERAPY;

EID: 33846406366     PISSN: 02567040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00381-006-0178-4     Document Type: Article

References (14)

1. Amlashi SF, Riffaud L, Brassier G, Morandi X (2003) Nevoid basal cell carcinoma syndrome: Relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature. Cancer 98:618-624
2. Cowan R, Hoban P, Kelsey A, Birch JN, Gattamaneni R, Evans DG (1997) The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma. Br J Cancer 76:141-145
3. Evans DG, Farndon PA, Burnell LD, Gattamaneni R, and Birch JN (1991) The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma. Br J Cancer 64:959-961
4. Evans DG, Birch JM, Orton C (1991) Brain tumours and the occurrence of severe invasive basal cell carcinomas in first degree relatives with Gorlin syndrome. Br J Neurosurg 5:643-646
5. Evans DG, Farndon, PA (2002) Nevoid Basal Cell Carcinoma Syndrome. http://www.genetests.org, 1-16. 6-10-0004. University of Washington, Seattle (Electronic Citation)
6. Gajjar A, Hernan R, Kocak M, Fuller C, Lee Y, McKinnon PJ et al (2004) Clinical, histopathologic, and molecular markers of prognosis: Toward a new disease risk stratification system for medulloblastoma. J Clin Oncol 22:984-993
7. Giangaspero F, Perilongo G, Fondelli MP, Brisgiotti M, Carollo C, Burnelli R et al (1999) Medulloblastoma with extensive nodularity: A variant with favorable prognosis. J Neurosurg 91:971-977
8. Gilbertson RJ (2004) Medulloblastoma: Signalling a change in treatment. Lancet Oncol 5:209-218
9. Heideman RL (2001) Overview of the treatment of infant central nervous system tumors: Medulloblastoma as a model. J Pediatr Hematol Oncol 23:268-271
10. Kortmann RD, Kuhl J, Timmermann B, Mittler U, Urban C, Budach V et al (2000) Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: Results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 46:269-279
11. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE (2004) Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 5:399-408
12. O'Malley S, Weitman D, Olding M et al (1997) Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome. Case report. J Neurosurg 86:286-288
13. Stavrou T, Bromley CM, Nicholson HS et al (2001) Prognostic factors and secondary malignancies in childhood medulloblastoma. J Pediatr Hematol Oncol 23:431-436
14. Zeltzer PM, Boyett JM, Finlay JL, Albright AL, Rorke LB, Milstein JM et al (1999) Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: Conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 17:832-845